(Q40034536)

16 September 2017

Role of glycosaminoglycans for binding and infection of hepatitis B virus (English)

1 reference

16 September 2017

1 reference

1 reference

Corinna M Leistner

1

1 reference

PubMed ID

18086046

16 September 2017

Stefanie Gruen-Bernhard

series ordinal

2

1 reference

PubMed ID

18086046

16 September 2017

Dieter Glebe

series ordinal

3

1 reference

16 September 2017

1 January 2008

1 reference

16 September 2017

Cellular Microbiology

1 reference

16 September 2017

10

1 reference

16 September 2017

122-133

1 reference

16 September 2017

1

1 reference

Pathogenesis of hepatitis B virus infection.

16 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Interaction of the N-terminal domain of apolipoprotein E4 with heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Internalization and stepwise degradation of heparan sulfate proteoglycans in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Molecular diversity of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Order out of chaos: assembly of ligand binding sites in heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Viral and cellular determinants involved in hepadnaviral entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Infection of a human hepatoma cell line by hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Heparan sulphate proteoglycans: the sweet side of development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Rat heparins. A study of the relative sizes and antithrombin-binding characteristics of heparin proteoglycans, chains and depolymerization products from rat adipose tissue, heart, lungs, peritoneal cavity and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Quantification of hepatitis B virus genomes and infectivity in human serum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Interactions between heparan sulfate and proteins: the concept of specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Characterization of novel Alu- and tRNA-related SINEs from the tree shrew and evolutionary implications of their origins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Sulfated polyanions do not inhibit duck hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Structure and metabolism of rat liver heparan sulphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Interaction between desialylated hepatitis B virus and asialoglycoprotein receptor on hepatocytes may be indispensable for viral binding and entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Direct measurement of the interactions of glycosaminoglycans and a heparin decasaccharide with the malaria circumsporozoite protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Fluid-phase markers in the basolateral endocytic pathway accumulate in response to the actin assembly-promoting drug Jasplakinolide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

The asialoglycoprotein receptor: a model for endocytic transport receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Antiviral therapy and resistance with hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Receptor-mediated entry of hepatitis B virus particles into liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Sulphated and sulphonated polymers inhibit the initial interaction of hepatitis B virus with hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1462-5822.2007.01023.X

10.1111/J.1462-5822.2007.01023.X

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference

PubMed ID

18086046